Clinical Trial

A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 20, 2026 (before its estimated May 2026 completion). Its status may not reflect the trial's current state.
Summary
A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232
Trial Details
NCT Number NCT07538466
Lead Sponsor Addpharma Inc.
Conditions Diabetes Mellitus
Enrollment 50 participants
Start Date 2026-04
Primary Completion 2026-05 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-20